COVID-19 vaccines and filler reactions: Should it be considered as a concern?

Autor: Aryanian Z; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Babol University of Medical Sciences, Babol, Iran., Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Emadi SN; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Razavi Z; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Hatami P; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Afshar ZM; Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Jazyk: angličtina
Zdroj: Journal of cosmetic dermatology [J Cosmet Dermatol] 2022 Dec; Vol. 21 (12), pp. 6564-6567. Date of Electronic Publication: 2022 Oct 14.
DOI: 10.1111/jocd.15428
Abstrakt: Background: Any implant or external material used in the body tissues can potentially be followed by autoimmune or inflammatory reactions. With the global vaccination program against COVID-19, the reports of tissue filler reactions would be increasingly demonstrated.
Aim: To summarize the data regarding COVID vaccination and filler reactions.
Method: We reviewed the existing data in this regard through searching on PubMed, Google Scholar and Scopus. All of the relevant papers published until March 2022, which we could access to their fulltexts were included.
Results: Here, we summarized the data regarding COVID-19 vaccination and filler reactions and discussed its etiopathogenesis, management, and importance.
Conclusion: Although the end of pandemic was announced, the necessity of continuing COVI-D19 vaccination in future mandates gathering data regarding safety of vaccines.
(© 2022 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje